bioMérieux – First-Quarter 2016 Business Review

26 April, 2016

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2016. 

bioMérieux – First-Quarter 2016 Business Review

Solid growth in sales, up 11.5% at constant exchange rates and scope of consolidation

  •  €489 million in sales
  • Up 9.1% as reported

Americas (up 22.5%) confirms its role as a key growth driver for the Group

Clinical microbiology: up 6.7%, driven primarily by successful sales of the VITEK® and BacT/ALERT® lines

FilmArray® Torch high-throughput system CE marked and FDA cleared with all four existing FilmArray® panels 

For more information and full text please klick on PDF button below.

Download
Pioneering Diagnostics